passlisted in Coinbase#9 by calls of 844 on this host
0.005 USDC
per call, as the listing declares it on eip155:
- Validation state
- pass
- Uptime, 7 / 30 / 90 days
- 100% / 100% / 100%
- Calls, trailing 30 days
- 2
- Unique payers, trailing 30 days
- 1
- Last called
- 2026-09-28 14:19 UTC
- First observed by TOLLderived
- 2026-09-28
- Pricederived
- 0.005 USDC
- Networks
- 1
How big is this endpoint among the ones like it?
No trace is drawn of this endpoint’s own volume. Its counters have changed 1 time across 8 observations, and 3 changes are the fewest this site will draw a trace through, because two points and a guess are not a series. Every observation is in the JSON.
calc irae hypothyroidism first appeared in TOLL's pulls on 2026-09-28.
At api.magentlab.com, calc irae hypothyroidism takes POST requests, is listed in the Coinbase registry, and falls under search by TOLL's rules.
A call to calc irae hypothyroidism costs 0.005 USDC on Base, as declared.
Its declared inputs are a JSON body with the field items.
calc irae hypothyroidism answered the sweep of 2026-09-30 with a valid 402, as at every sweep since 2026-09-28.
A response from calc irae hypothyroidism, as declared, includes path, count and items.
Among the 844 endpoints on api.magentlab.com, calc irae hypothyroidism is tied 9th by calls with 248 others.
calc irae hypothyroidism drew 2 calls from one payer in the trailing 30 days.
The last call to calc irae hypothyroidism came 3 days before the snapshot, 2026-09-28.
Closest in price to calc irae hypothyroidism within search: apollo org search at apollo.x402.paywithlocus.com and agentsearch web search v1 at agent.pocket.network.
calc irae hypothyroidism is priced above 26% of comparable listings in search.
The payee wallet is shared by 844 listings on one host.
The seller's tags on calc irae hypothyroidism are irae-hypothyroidism, thyroid, immunotherapy and asco.
Exactly this price appears on 318 other listings in search.
the payment options, as of 2026-10-01 05:50 UTC · method · pinnable
| registry | network | asset | amount | scheme | pay to |
|---|---|---|---|---|---|
| Coinbase | eip155: | USDC | 0.005 USDC | exact | 0x836Be2…c19Ee2 |
the checks, as of 2026-09-30 08:52 UTC · method · pinnableendpoint answered HTTP 402
No named check failed.
Every sweep that observed this endpoint, newest first.
| observed, UTC | state | failed checks | sweep |
|---|---|---|---|
| 2026-09-30 08:52 UTC | pass | 0 | daily-2026-09-30 |
| 2026-09-29 20:57 UTC | pass | 0 | daily-2026-09-29 |
| 2026-09-28 16:48 UTC | pass | 0 | new-after-daily-2026-09-28 |
Presence in a registry, not liveness of the service (method). Newest first.
- listed in Coinbase
From the registry record, not validated by TOLL.the declared schema, as of 2026-09-28 14:19 UTC · method · live
The input and output block
{
"input": {
"body": {
"items": [
{
"tsh_miu_l": 8,
"moderate_symptoms": false,
"unable_to_perform_adl": false,
"severe_or_life_threatening": false
},
{
"tsh_miu_l": 8,
"moderate_symptoms": false,
"unable_to_perform_adl": false,
"severe_or_life_threatening": false
}
]
},
"type": "http",
"method": "POST"
},
"output": {
"type": "json",
"example": {
"path": "/api/calc/irae_hypothyroidism",
"count": 2,
"items": [
{
"grade": 1,
"formula": "irae_hypothyroidism",
"citation": {
"id": "brahmer-2018",
"doi": "10.1200/JCO.2017.77.6385",
"pmid": "29442540",
"title": "Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline",
"source": "J Clin Oncol. 2018;36(17):1714-1768",
"authors": "Brahmer JR, Lacchetti C, Schneider BJ, Atkins MB, Brassil KJ, Caterino JM, Chau I, Ernstoff MS, Gardner JM, Ginex P, Hallmeyer S, Holter Chakrabarty J, Leighl NB, Mammen JS, McDermott DF, Naing A, Nastoupil LJ, Phillips T, Porter LD, Puzanov I, Reichner CA, Santomasso BD, Seigel C, Spira A, Suarez-Almazor ME, Wang Y, Weber JS, Wolchok JD, Thompson JA"
},
"criteria": [
{
"met": false,
"factor": "severe_or_life_threatening"
},
{
"met": false,
"factor": "unable_to_perform_adl"
},
{
"met": false,
"factor": "moderate_symptoms"
},
{
"met": false,
"value": 8,
"factor": "tsh_ge_10"
}
],
"tsh_miu_l": 8,
"disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
"icpi_action": "continue",
"moderate_symptoms": false,
"formula_expression": "irae hypothyroidism first-match (Brahmer 2018 Table 4.1.1 primary hypothyroidism): grade 3 if severe_or_life_threatening or unable_to_perform_adl (paper G3-4 as grade 3); else grade 2 if moderate_symptoms or tsh_miu_l >= 10; else grade 1 if tsh_miu_l < 10. icpi_action continue (1), hold_until_baseline (2 and 3). Not hyperthyroidism (Table 4.1.2). magent does not assay TSH/FT4. Not a diagnosis. Not a levothyroxine dose",
"unable_to_perform_adl": false,
"severe_or_life_threatening": false
},
{
"grade": 1,
"formula": "irae_hypothyroidism",
"citation": {
"id": "brahmer-2018",
"doi": "10.1200/JCO.2017.77.6385",
"pmid": "29442540",
"title": "Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline",
"source": "J Clin Oncol. 2018;36(17):1714-1768",
"authors": "Brahmer JR, Lacchetti C, Schneider BJ, Atkins MB, Brassil KJ, Caterino JM, Chau I, Ernstoff MS, Gardner JM, Ginex P, Hallmeyer S, Holter Chakrabarty J, Leighl NB, Mammen JS, McDermott DF, Naing A, Nastoupil LJ, Phillips T, Porter LD, Puzanov I, Reichner CA, Santomasso BD, Seigel C, Spira A, Suarez-Almazor ME, Wang Y, Weber JS, Wolchok JD, Thompson JA"
},
"criteria": [
{
"met": false,
"factor": "severe_or_life_threatening"
},
{
"met": false,
"factor": "unable_to_perform_adl"
},
{
"met": false,
"factor": "moderate_symptoms"
},
{
"met": false,
"value": 8,
"factor": "tsh_ge_10"
}
],
"tsh_miu_l": 8,
"disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
"icpi_action": "continue",
"moderate_symptoms": false,
"formula_expression": "irae hypothyroidism first-match (Brahmer 2018 Table 4.1.1 primary hypothyroidism): grade 3 if severe_or_life_threatening or unable_to_perform_adl (paper G3-4 as grade 3); else grade 2 if moderate_symptoms or tsh_miu_l >= 10; else grade 1 if tsh_miu_l < 10. icpi_action continue (1), hold_until_baseline (2 and 3). Not hyperthyroidism (Table 4.1.2). magent does not assay TSH/FT4. Not a diagnosis. Not a levothyroxine dose",
"unable_to_perform_adl": false,
"severe_or_life_threatening": false
}
]
}
}
}Cite this page
The pinned URL below renders this page from the snapshot of 2026-10-01 05:50 UTC and does not change; the live page does, every six hours. Data reuse is under CC BY 4.0 (terms).
Plain text
TOLL, "calc irae hypothyroidism on api.magentlab.com", snapshot of 2026-10-01 05:50 UTC. https://tollindex.com/e/api-magentlab-com-api-calc-irae-hypothyroidism-ca8018/at/2026-10-01T05-50Z. Accessed [access date].
BibTeX
@misc{toll-e-api-magentlab-com-api-calc-irae-hypothyroidism-ca8018-2026-10-01T05-50Z,
author = {TOLL},
title = {calc irae hypothyroidism on api.magentlab.com},
howpublished = {\url{https://tollindex.com/e/api-magentlab-com-api-calc-irae-hypothyroidism-ca8018/at/2026-10-01T05-50Z}},
year = {2026},
month = {10},
note = {Pinned view of the snapshot of 2026-10-01 05:50 UTC. Accessed [access date].}
}None yet. Anything submitted through the form below is published here with its outcome.